173 related articles for article (PubMed ID: 33622252)
1. Activin a suppresses peripheral CD8
Wu Q; Weng R; Xu Y; Wang L; Huang Y; Yang J
BMC Immunol; 2021 Feb; 22(1):17. PubMed ID: 33622252
[TBL] [Abstract][Full Text] [Related]
2. Frequencies of PD-1- and PD-L1- positive T CD3
Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
5. Effect of Activin A on activation status of monocytes in acute-phase Kawasaki disease.
Wu Q; Yang Z; Huang Y; Wang L; Weng R; Yang J
Clin Exp Med; 2021 Aug; 21(3):407-414. PubMed ID: 33630201
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
7. Expression of lymphocyte activation markers of preterm neonates is associated with perinatal complications.
Sava F; Toldi G; Treszl A; Hajdú J; Harmath Á; Tulassay T; Vásárhelyi B
BMC Immunol; 2016 Jun; 17(1):19. PubMed ID: 27328920
[TBL] [Abstract][Full Text] [Related]
8. T cell activation profiles in Kawasaki syndrome.
Brogan PA; Shah V; Clarke LA; Dillon MJ; Klein N
Clin Exp Immunol; 2008 Feb; 151(2):267-74. PubMed ID: 18070150
[TBL] [Abstract][Full Text] [Related]
9. Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.
Rowley AH; Baker SC; Kim KA; Shulman ST; Yang A; Arrollo D; DeBerge M; Han S; Sibinga NES; Pink AJ; Thorp EB
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e94-e102. PubMed ID: 28505365
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
11. T cells in sputum of asthmatic patients are activated independently of disease severity or control.
Lourenço O; Mafalda Fonseca A; Taborda-Barata L
Allergol Immunopathol (Madr); 2009; 37(6):285-92. PubMed ID: 19850398
[TBL] [Abstract][Full Text] [Related]
12. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
Zhang YY; Huang XM; Kang ML; Gong FQ; Qian BQ
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):329-32. PubMed ID: 16780706
[TBL] [Abstract][Full Text] [Related]
13. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease.
Ehara H; Kiyohara K; Izumisawa Y; Ito T
Cell Immunol; 2010; 265(1):57-64. PubMed ID: 20673885
[TBL] [Abstract][Full Text] [Related]
14. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
15. Functions of human liver CD69
Kim JH; Han JW; Choi YJ; Rha MS; Koh JY; Kim KH; Kim CG; Lee YJ; Kim AR; Park J; Kim HK; Min BS; Seo SI; Kang M; Park HJ; Han DH; Kim SI; Kim MS; Lee JG; Lee DH; Kim W; Park JY; Park SH; Joo DJ; Shin EC
J Hepatol; 2020 Jun; 72(6):1170-1181. PubMed ID: 31987989
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease.
Sun M; Xing H
Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
18. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated expression of CD69 and IL-2 receptor alpha and beta chains on CD8+ T lymphocytes in flaky skin mice.
Abernethy NJ; Hagan C; Tan PL; Watson JD
Immunol Cell Biol; 2000 Dec; 78(6):596-602. PubMed ID: 11114969
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
